2. Academic Validation
  3. A Cdk5 inhibitor restores cognitive function and alleviates type 2 diabetes in mice

A Cdk5 inhibitor restores cognitive function and alleviates type 2 diabetes in mice

  • iScience. 2025 Mar 11;28(4):112200. doi: 10.1016/j.isci.2025.112200.
Sangita Paul 1 2,  Remya Chandran 3,  Dileep K Vijayan 3,  Juhi Bhardwaj 1 2,  Praveen Singh 1 2,  Poornima Shetty 4,  Srinivas Cheruku 5,  Sajith Meleveetil 6,  Binukumar Balachandran Krishnamma 1 2
Affiliations

Affiliations

  • 1 CSIR Institute of Genomics and Integrative Biology, New Delhi, India.
  • 2 Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
  • 3 Laboratory for Computational and Structural Biology, Jubilee Centre for Medical Research, Jubilee Mission Medical College and Research Institute, Thrissur 680005, Kerala, India.
  • 4 Srinivasa Engineering College, Mukka, Mangalore 574146, India.
  • 5 Department of Chemistry, Manasa Gangotri, Mysore University, Mysuru 570005, India.
  • 6 Department of Chemistry, SSIT, Sri Siddhartha Academy of Higher Education, Tumkur 572107, Karnataka, India.
PMID: 40224020 DOI: 10.1016/j.isci.2025.112200
Abstract

Type 2 diabetes (T2D) is a metabolic disorder commonly linked with cognitive decline, increasing patients' susceptibility to dementia. Alzheimer's disease (AD) has a strong connection with hyperglycemia and Insulin dysregulation. Interestingly, certain anti-diabetic drugs have shown potential in reducing T2D-induced cognitive impairment. Previous studies, including ours, have highlighted the dysregulation of cyclin-dependent kinase 5 (CDK5) activity in both T2D and AD, which may contribute to pathological changes in these conditions. Thus, targeting the CDK5 kinase could offer a therapeutic approach for T2D and cognitive deterioration. Our research identifies CDK5 as a key link between T2D and cognitive decline. By screening the KINACore library, we discovered two new brain-penetrant CDK5 inhibitors, BLINK11 and BLINK15. In a high-fat diet-induced T2D model, these inhibitors improved blood glucose levels, obesity, and cognitive function. BLINK11, in particular, shows promise as a therapeutic candidate for treating cognitive impairment associated with T2D.

Keywords

Biological sciences; Endocrinology; Natural sciences; Neuroscience; Pharmacology; Physiology.

Figures
Products